"There are actually five routes for vaccine research in COVID-19, namely whole virus inactivated vaccine, genetic engineering subunit vaccine, adenovirus vector vaccine, attenuated influenza virus vector vaccine and nucleic acid vaccine. Among them, nucleic acid vaccines are mRNA and DNA vaccines. " After the outbreak, Sinopharm Group concentrated on breaking through the whole virus inactivated vaccine. ?
China Institute of Biological Products of Sinopharm Group and Beijing Institute of Biological Products are conducting parallel research on inactivated vaccine routes, and China Institute of Biotechnology of Sinopharm Group is conducting research on genetic engineering subunit vaccines.
Extended data:
Domestic inactivated COVID-19 vaccine is introduced as follows:
The inactivated COVID-19 vaccine developed by Wuhan Institute of Biological Products entered the first and second phase of clinical research. On June 16, the clinical trial results were released. The results showed that the vaccine was safe after vaccination, and there were no serious adverse reactions. After inoculation with different procedures and doses, the vaccinators all produced high titer antibodies.
The inactivated vaccine developed by Beijing Institute of Biological Products entered clinical research, and the first and second clinical results were announced on June 28th. On June 23rd, Sinopharm Group launched the third international clinical trial in UAE.
People's Daily Online-COVID-19 speeds up the research and development of inactivated vaccine.
Phoenix net-heavy! Hundreds of thousands of people were vaccinated with inactivated vaccine made in COVID-19, and no infection occurred.